Arrowstreet Capital
CDNA icon

Arrowstreet Capital’s CareDx CDNA Stock Holding History

Arrowstreet Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-38,580
Closed -$685K – 1938
2025
Q1 		$685K Buy
38,580
+4,418
+13% +$95.2K ﹤0.01% 1567
2024
Q4 		$731K Buy
+34,162
New +$831K ﹤0.01% 1521
2024
Q2 		– Sell
-216,891
Closed -$2.3M – 1546
2024
Q1 		$2.3M Sell
216,891
-129,006
-37% -$1.29M ﹤0.01% 1102
2023
Q4 		$4.15M Buy
+345,897
New +$2.83M ﹤0.01% 803
2021
Q4 		– Sell
-11,900
Closed -$754K – 1465
2021
Q3 		$754K Sell
11,900
-12,600
-51% -$960K ﹤0.01% 1352
2021
Q2 		$2.24M Buy
24,500
+16,600
+210% +$1.32M ﹤0.01% 1313
2021
Q1 		$538K Buy
+7,900
New +$613K ﹤0.01% 1976
2020
Q4 		– Sell
-20,724
Closed -$786K – 2304
2020
Q3 		$786K Buy
+20,724
New +$700K ﹤0.01% 1884

Other funds holding CDNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return

Arrowstreet Capital's CDNA Position: Q2 2025 in Review

Arrowstreet Capital sold out of CareDx (CDNA) in Q2 2025, closing a stake of 38,580 shares — an estimated $685K sold.

Arrowstreet Capital first reported a position in CDNA in Q3 2020 and held it in 8 quarters. The position peaked at $4.15M in Q4 2023. 197 funds tracked by Wall St. Rank hold CDNA as of Q2 2025.

  • Arrowstreet Capital reported no remaining CareDx position as of Q2 2025 after selling out during the quarter.
  • Arrowstreet Capital sold 38,580 CareDx shares in Q2 2025, an estimated $685K.
  • Arrowstreet Capital first reported a position in CareDx in Q3 2020 and held it in 8 quarters.
  • Arrowstreet Capital's CareDx position peaked at $4.15M in Q4 2023.
  • 197 funds tracked by Wall St. Rank held CareDx as of Q2 2025.

Based on Arrowstreet Capital's 13F filing for Q2 2025, filed 13 Aug 2025.